Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are prescription drugs that mimic or boost the effects of the glucagon-like peptide-1 (GLP-1), which is a hormone released in response to eating
Pancreatitis: discontinue if suspected
95% CI 0.89, 0.96), compared with other second- or third-line glucose-lowering medications
We may ship a vial to you that is more secure than individual injections
Chest pain, shortness of breath, or rapid heart rate : which could indicate cardiovascular complications Severe weakness or inability to perform normal activities : suggesting possible electrolyte imbalances or other serious conditions You should also schedule a non-urgent appointment if you notice unintentional excessive weight loss (more than 23 pounds per week consistently), difficulty maintaining adequate nutrition , or new symptoms such as cold intolerance, hair loss, or mood changes that might suggest thyroid dysfunction or other endocrine issues
Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms